Serum albumin: Difference between revisions
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content) | |blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content) | ||
|fdaLIADAdult======Emergency Treatment of Hypovolemic Shock===== | |fdaLIADAdult======Emergency Treatment of Hypovolemic Shock===== | ||
Albuked 5 is iso-oncotic with normal plasma and on intravenous infusion will expand the circulating blood volume by an amount approximately equal to the volume infused. In conditions associated mainly with a volume deficit, albumin is best administered as a 5% solution (Albuked 5); but where there is an oncotic deficit, Albumin (Human) 25%, USP (Albuked™ 25) may be preferred. This is also an important consideration where the treatment of the shock state has been delayed. If Albuked 25 is used, appropriate additional crystalloid should be administered. | Albuked 5 is iso-oncotic with normal plasma and on intravenous infusion will expand the circulating blood volume by an amount approximately equal to the volume infused. In conditions associated mainly with a volume deficit, albumin is best administered as a 5% solution (Albuked 5); but where there is an oncotic deficit, Albumin (Human) 25%, USP (Albuked™ 25) may be preferred. This is also an important consideration where the treatment of the shock state has been delayed. If Albuked 25 is used, appropriate additional crystalloid should be administered. | ||
Crystalloid solutions in volumes several times greater than that of Albuked 5 may be effective in treating shock in younger individuals who have no preexisting illness at the time of the incident. Older patients, especially those with preexisting debilitating conditions, or those in whom the shock is caused by a medical disorder, or where the state of shock has existed for some time before active therapy could be instituted, may not tolerate hypoalbuminemia as well.(1) | [[Crystalloid solutions]] in volumes several times greater than that of Albuked 5 may be effective in treating [[shock]] in younger individuals who have no preexisting illness at the time of the incident. Older patients, especially those with preexisting debilitating conditions, or those in whom the [[shock]] is caused by a medical disorder, or where the state of shock has existed for some time before active therapy could be instituted, may not tolerate [[hypoalbuminemia]] as well.(1) | ||
Removal of ascitic fluid from a patient with cirrhosis may cause changes in cardiovascular function and even result in hypovolemic shock. In such circumstances, the use of albumin infusion may be required to support the blood volume. | Removal of [[ascitic fluid]] from a patient with [[cirrhosis]] may cause changes in cardiovascular function and even result in [[hypovolemic shock]]. In such circumstances, the use of albumin infusion may be required to support the [[blood volume]]. | ||
=====Burn Therapy===== | =====Burn Therapy===== | ||
An optimal therapeutic regimen with respect to the administration of colloids, crystalloids, and water following extensive burns has not been established. During the first 24 hours after sustaining thermal injury, large volumes of crystalloids are infused to restore the depleted extracellular fluid volume. Beyond 24 hours, albumin can be used to maintain plasma colloid osmotic pressure. Albuked 25 may be preferred for this purpose. | An optimal therapeutic regimen with respect to the administration of [[colloids]], [[crystalloids]], and water following extensive burns has not been established. During the first 24 hours after sustaining thermal injury, large volumes of crystalloids are infused to restore the depleted extracellular fluid volume. Beyond 24 hours, albumin can be used to maintain plasma [[colloid osmotic pressure]]. Albuked 25 may be preferred for this purpose. | ||
=====Cardiopulmonary Bypass===== | =====Cardiopulmonary Bypass===== | ||
With the relatively small priming volume required with modern pumps, preoperative dilution of the blood using albumin and crystalloid has been shown to be safe and well-tolerated. Although the limit to which the hematocrit and plasma protein concentration can be safely lowered has not been defined, it is common practice to adjust the albumin and crystalloid pump prime to achieve a hematocrit of 20% and a plasma albumin concentration of 2.5 g per 100 mL in the patient. | With the relatively small priming volume required with modern pumps, preoperative dilution of the blood using [[albumin]] and [[crystalloid]] has been shown to be safe and well-tolerated. Although the limit to which the [[hematocrit]] and plasma protein concentration can be safely lowered has not been defined, it is common practice to adjust the [[albumin]] and [[crystalloid]] pump prime to achieve a [[hematocrit]] of 20% and a plasma albumin concentration of 2.5 g per 100 mL in the patient. | ||
=====Acute Liver Failure===== | =====Acute Liver Failure===== | ||
In the uncommon situation of rapid loss of liver function, with or without coma, administration of albumin may serve the double purpose of supporting the colloid osmotic pressure of the plasma as well as binding excess plasma bilirubin. | In the uncommon situation of rapid loss of [[liver function[[, with or without [[coma]], administration of albumin may serve the double purpose of supporting the [[colloid osmotic pressure]] of the [[plasma]] as well as binding excess [[plasma bilirubin]]. | ||
=====Sequestration of Protein Rich Fluids===== | =====Sequestration of Protein Rich Fluids===== | ||
This occurs in such conditions as acute peritonitis, pancreatitis, mediastinitis, and extensive cellulitis. The magnitude of loss into the third space may require treatment of reduced volume or oncotic activity with an infusion of albumin. | This occurs in such conditions as acute [[peritonitis]], [[pancreatitis]], [[mediastinitis]], and extensive [[cellulitis]]. The magnitude of loss into the third space may require treatment of reduced volume or [[oncotic]] activity with an infusion of albumin. | ||
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of Serum albumin in adult patients. | |offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of Serum albumin in adult patients. | ||
|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Serum albumin in adult patients. | |offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Serum albumin in adult patients. | ||
Revision as of 21:18, 7 January 2015
{{DrugProjectFormSinglePage |authorTag=Alberto Plate [1] |genericName=Serum albumin |aOrAn=a |drugClass=volume expander |indicationType=treatment |indication=burn therapy, Cardiopulmonary bypass, hypovolemic shock, acute liver failure and sequestration of protein rich fluids |blackBoxWarningTitle=TITLE |blackBoxWarningBody=Condition Name: (Content) |fdaLIADAdult======Emergency Treatment of Hypovolemic Shock===== Albuked 5 is iso-oncotic with normal plasma and on intravenous infusion will expand the circulating blood volume by an amount approximately equal to the volume infused. In conditions associated mainly with a volume deficit, albumin is best administered as a 5% solution (Albuked 5); but where there is an oncotic deficit, Albumin (Human) 25%, USP (Albuked™ 25) may be preferred. This is also an important consideration where the treatment of the shock state has been delayed. If Albuked 25 is used, appropriate additional crystalloid should be administered.
Crystalloid solutions in volumes several times greater than that of Albuked 5 may be effective in treating shock in younger individuals who have no preexisting illness at the time of the incident. Older patients, especially those with preexisting debilitating conditions, or those in whom the shock is caused by a medical disorder, or where the state of shock has existed for some time before active therapy could be instituted, may not tolerate hypoalbuminemia as well.(1)
Removal of ascitic fluid from a patient with cirrhosis may cause changes in cardiovascular function and even result in hypovolemic shock. In such circumstances, the use of albumin infusion may be required to support the blood volume.
Burn Therapy
An optimal therapeutic regimen with respect to the administration of colloids, crystalloids, and water following extensive burns has not been established. During the first 24 hours after sustaining thermal injury, large volumes of crystalloids are infused to restore the depleted extracellular fluid volume. Beyond 24 hours, albumin can be used to maintain plasma colloid osmotic pressure. Albuked 25 may be preferred for this purpose.
Cardiopulmonary Bypass
With the relatively small priming volume required with modern pumps, preoperative dilution of the blood using albumin and crystalloid has been shown to be safe and well-tolerated. Although the limit to which the hematocrit and plasma protein concentration can be safely lowered has not been defined, it is common practice to adjust the albumin and crystalloid pump prime to achieve a hematocrit of 20% and a plasma albumin concentration of 2.5 g per 100 mL in the patient.
Acute Liver Failure
In the uncommon situation of rapid loss of [[liver function[[, with or without coma, administration of albumin may serve the double purpose of supporting the colloid osmotic pressure of the plasma as well as binding excess plasma bilirubin.
Sequestration of Protein Rich Fluids
This occurs in such conditions as acute peritonitis, pancreatitis, mediastinitis, and extensive cellulitis. The magnitude of loss into the third space may require treatment of reduced volume or oncotic activity with an infusion of albumin. |offLabelAdultGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Serum albumin in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Serum albumin in adult patients. |offLabelPedGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Serum albumin in pediatric patients. |offLabelPedNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Serum albumin in pediatric patients. |alcohol=Alcohol-Serum albumin interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication. }}
|
WikiDoc Resources for Serum albumin |
|
Articles |
|---|
|
Most recent articles on Serum albumin Most cited articles on Serum albumin |
|
Media |
|
Powerpoint slides on Serum albumin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Serum albumin at Clinical Trials.gov Trial results on Serum albumin Clinical Trials on Serum albumin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Serum albumin NICE Guidance on Serum albumin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Serum albumin Discussion groups on Serum albumin Patient Handouts on Serum albumin Directions to Hospitals Treating Serum albumin Risk calculators and risk factors for Serum albumin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Serum albumin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Overview
Serum albumin, often referred to simply as albumin, is the most abundant plasma protein in humans and other mammals. Albumin is essential for maintaining the osmotic pressure needed for proper distribution of body fluids between intravascular compartments and body tissues. It also acts as a plasma carrier by non-specifically binding several hydrophobic steroid hormones and as a transport protein for hemin and fatty acids.
Classification
- The human version is human serum albumin.
- Bovine serum albumin, or BSA, is commonly used in immunodiagnostic procedures, clinical chemistry reagents, cell culture media, protein chemistry research and molecular biology laboratories.
Pathophysiology
Albumin is negatively charged. The glomerular basement membrane is also negatively charged; some studies suggest that this prevents the filtration of albumin in the urine. According to this theory, that charge plays a major role in the selective exclusion of albumin from the glomerular filtrate, a defect in this property results in nephrotic syndrome. Thus, there is more albumin loss in the urine. Nephrotic syndrome patients are sometimes given albumin to replace the lost albumin.
Because smaller animals (for example rats) function at a lower blood pressure, they need less oncotic pressure to balance this, and thus need less albumin to maintain proper fluid distribution.
Serum albumin contains eleven distinct binding domains for hydrophobic compounds. One hemin and six long-chain fatty acids can bind to serum albumin at the same time [1].
References